Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 24 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of J B Chemicals & Pharmaceuticals Ltd

About the Company - J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2189.88 Cr. and Equity Capital is Rs. 15.46 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsNeelam Centre, 'B' Wing, 4th floor, Mumbai Maharashtra 400030secretarial@jbcpl.com
https://jbpharma.com
Management
NamePosition Held
Mr. Ranjit ShahaniChairman & Ind.Director
Mr. Nikhil ChopraWholeTime Director & CEO
Mr. Prashant KumarNon Executive Director
Mr. Gaurav TrehanNon Executive Director
Mr. Sumit BoseIndependent Director
Ms. Padmini Khare KaickerIndependent Director

J B Chemicals & Pharmaceuticals Ltd. Share Price Update

Share PriceValue
Today₹1,663.70
Previous Day₹1,679.40

Basic Stock Data of J B Chemicals & Pharmaceuticals Ltd

Market Cap 25,702 Cr.
Current Price 1,657
High / Low1,940/875
Stock P/E50.0
Book Value 175
Dividend Yield0.52 %
ROCE22.4 %
ROE17.6 %
Face Value 1.00

Data Source: screener.in

Competitors of J B Chemicals & Pharmaceuticals Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Morepen Laboratories Ltd 2,732 Cr. 53.456.4/24.035.9 15.40.00 %8.57 %5.93 % 2.00
Glaxosmithkline Pharmaceuticals Ltd 38,658 Cr. 2,2822,650/1,22760.3 90.91.38 %36.4 %26.8 % 10.0
Vaishali Pharma Ltd 168 Cr. 159204/11528.8 41.80.00 %21.7 %19.7 % 10.0
Torrent Pharmaceuticals Ltd 89,065 Cr. 2,6322,700/1,44662.2 1980.83 %19.8 %20.0 % 5.00
TTK Healthcare Ltd 2,106 Cr. 1,4901,584/82832.4 6880.67 %10.1 %99.7 % 10.0
Industry Average59.8 Cr43.4843.92206.820.58%19.31%34.43%7.4

J B Chemicals & Pharmaceuticals Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales444548528606593601625785809793762896882
Expenses333377405442466473500612625618599664638
Operating Profit110171124164127128125173185175164232244
OPM %25%31%23%27%21%21%20%22%23%22%21%26%28%
Other Income85625132052113568
Interest2111112688141210
Depreciation17171718161722262828323132
Profit before tax99208132158129114103142150141122194209
Tax %26%26%24%25%24%26%18%26%26%25%28%27%28%
Net Profit7415410111998848510511110688142151
EPS in Rs4.779.976.517.696.325.435.496.797.186.865.669.199.72

J B Chemicals & Pharmaceuticals Ltd Quarterly Chart

J B Chemicals & Pharmaceuticals Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales8028661,0221,1441,2101,3441,4081,6431,7752,0432,4243,1493,333
Expenses7017608749641,0041,1121,1911,3371,3971,4821,8812,4542,519
Operating Profit101106148180206232218306378560543696814
OPM %13%12%14%16%17%17%15%19%21%27%22%22%24%
Other Income78927-27115850374141112391021
Interest24467115353753645
Depreciation2225283941475756666973114124
Profit before tax84310487146212230194287349597505555667
Tax %20%23%30%31%23%20%28%32%22%25%24%26%
Net Profit6787962100163184139194272449386410487
EPS in Rs40.024.693.635.929.5810.858.2812.0517.6028.9824.9326.4831.43
Dividend Payout %51%32%41%118%26%5%12%21%31%28%33%34%

J B Chemicals & Pharmaceuticals Ltd Profit & Loss Yearly Chart

J B Chemicals & Pharmaceuticals Ltd Growth

Compounded Sales Growth
10 Years:14%
5 Years:17%
3 Years:21%
TTM:12%
Compounded Profit Growth
10 Years:21%
5 Years:31%
3 Years:16%
TTM:26%
Stock Price CAGR
10 Years:39%
5 Years:62%
3 Years:53%
1 Year:77%
Return on Equity
10 Years:15%
5 Years:18%
3 Years:20%
Last Year:18%

J B Chemicals & Pharmaceuticals Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital17171717171717161515151516
Reserves9531,0031,0269781,1671,3471,4251,4641,4201,7942,1192,4652,701
Borrowings715093127193492926294555572437
Other Liabilities157230215365270262294286349376412495645
Total Liabilities1,1981,3001,3511,4871,6481,6741,7651,7921,8142,2312,6013,5473,799
Fixed Assets2763343113294406796406216516341,2771,9011,917
CWIP3954655135417151626195572
Investments30239850055247941143445740367813206315
Other Assets5815634945525945806746997438941,2931,3851,495
Total Assets1,1981,3001,3511,4871,6481,6741,7651,7921,8142,2312,6013,5473,799

J B Chemicals & Pharmaceuticals Ltd Reserves and Borrowings Chart

J B Chemicals & Pharmaceuticals Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 88084-14127140201123194276315170626
Cash from Investing Activity -261-116-142-112-26-45-21-2824-2312-962
Cash from Financing Activity -526-3112-1-100-184-60-156-306-87-138357
Net Cash Flow93-63-1441315-284311-6-33420

J B Chemicals & Pharmaceuticals Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days628184848272786871708467
Inventory Days117104120122146138145149159181178134
Days Payable516054637168757297979775
Cash Conversion Cycle128124150143158142148146133153164127
Working Capital Days988099569688101978799127102
ROCE %11%8%13%13%15%14%11%18%23%33%23%22%

J B Chemicals & Pharmaceuticals Ltd Financial Efficiency Indicators Chart

J B Chemicals & Pharmaceuticals Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Promoters55.91%55.91%55.91%55.91%54.00%54.00%54.00%53.96%53.95%53.93%53.91%53.86%
FIIs7.87%7.54%8.37%8.74%9.12%9.22%8.85%8.66%8.81%8.62%9.53%10.05%
DIIs13.91%13.17%13.13%15.23%16.26%16.89%17.80%18.47%18.55%19.08%18.65%18.58%
Public22.31%23.38%22.58%20.12%20.62%19.89%19.35%18.91%18.72%18.35%17.90%17.50%
No. of Shareholders58,48865,71870,74071,78864,86161,31460,26858,62959,77956,63355,96560,817

J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern Chart

No. of J B Chemicals & Pharmaceuticals Ltd Shareholders

J B Chemicals & Pharmaceuticals Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Axis Small Cap Fund22074751.79320.28
Franklin India Smaller Companies Fund15889762.14230.54
Nippon India Pharma Fund14868683.48215.73
Nippon India Multi Cap Fund9859020.63143.04
Nippon India Small Cap Fund9378720.33136.08
Invesco India Contra Fund8047040.97116.75
Canara Robeco Small Cap Fund7900681.33114.63
HSBC Small Cap Fund - Regular Plan7251220.82105.21
Mirae Asset Healthcare Fund7013845.16101.76
Nippon India Growth Fund6842920.4699.28

J B Chemicals & Pharmaceuticals Ltd ROCE Trend

J B Chemicals & Pharmaceuticals Ltd EPS Trend

J B Chemicals & Pharmaceuticals Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)53.0049.8657.9634.2023.54
Diluted EPS (Rs.)52.3449.8657.9634.2023.54
Cash EPS (Rs.)67.7559.3566.9243.8331.11
Book Value[Excl.RevalReserv]/Share (Rs.)320.46276.73234.65186.07184.82
Book Value[Incl.RevalReserv]/Share (Rs.)320.46276.73234.65186.07184.82
Revenue From Operations / Share (Rs.)406.88313.69264.29229.64204.79
PBDIT / Share (Rs.)91.1775.4087.0655.4143.23
PBIT / Share (Rs.)76.3966.0078.1746.8336.29
PBT / Share (Rs.)71.7365.3377.2345.1535.77
Net Profit / Share (Rs.)52.9749.9558.0435.2524.17
NP After MI And SOA / Share (Rs.)52.9549.8657.9635.2024.11
PBDIT Margin (%)22.4024.0332.9324.1321.10
PBIT Margin (%)18.7721.0329.5720.3917.72
PBT Margin (%)17.6320.8229.2219.6517.46
Net Profit Margin (%)13.0115.9221.9515.3411.80
NP After MI And SOA Margin (%)13.0115.8921.9315.3211.77
Return on Networth / Equity (%)16.5218.0524.7518.9513.07
Return on Capital Employeed (%)19.7122.9331.9124.1118.81
Return On Assets (%)11.5314.7720.0115.0010.80
Long Term Debt / Equity (X)0.150.000.000.000.00
Total Debt / Equity (X)0.220.010.010.020.01
Asset Turnover Ratio (%)1.030.910.940.910.84
Current Ratio (X)2.803.324.503.434.32
Quick Ratio (X)2.032.253.492.553.31
Inventory Turnover Ratio (X)2.011.731.961.902.15
Dividend Payout Ratio (NP) (%)0.0033.0916.3852.0210.41
Dividend Payout Ratio (CP) (%)0.0027.8414.2141.828.08
Earning Retention Ratio (%)0.0066.9183.6247.9889.59
Cash Earning Retention Ratio (%)0.0072.1685.7958.1891.92
Interest Coverage Ratio (X)19.58113.7992.91141.3582.62
Interest Coverage Ratio (Post Tax) (X)12.3776.3962.9494.2147.20
Enterprise Value (Cr.)15724.2012145.749693.573932.222877.11
EV / Net Operating Revenue (X)4.995.014.752.221.75
EV / EBITDA (X)22.2820.8414.419.188.30
MarketCap / Net Operating Revenue (X)4.845.024.742.211.76
Retention Ratios (%)0.0066.9083.6147.9789.58
Price / BV (X)6.155.705.352.741.95
Price / Net Operating Revenue (X)4.845.024.742.211.76
EarningsYield0.020.030.040.060.06

J B Chemicals & Pharmaceuticals Ltd Profitability Ratios (%)

J B Chemicals & Pharmaceuticals Ltd Liquidity Ratios

J B Chemicals & Pharmaceuticals Ltd Liquidity Ratios (%)

J B Chemicals & Pharmaceuticals Ltd Interest Coverage Ratios (%)

J B Chemicals & Pharmaceuticals Ltd Valuation Ratios

Fair Value of J B Chemicals & Pharmaceuticals Ltd Stock

Fair Value: ₹1548.01

The stock is overvalued by 6.58% compared to the current price ₹1657

*Investments are subject to market risks

Strength and Weakness of J B Chemicals & Pharmaceuticals Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 17.00%, which is a positive sign.
  2. The company has higher reserves (1,527.85 cr) compared to borrowings (136.62 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (129.62 cr) and profit (367.38 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 60.74 and average Dividend Yield of 21.50%.
  2. The stock has a high average Working Capital Days of 94.17, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 143.00, which may not be favorable.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in J B Chemicals & Pharmaceuticals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE